part
search
botan
sourc
sarscov
pro
inhibitor
select
torreya
nucifera
tradit
use
medicin
plant
asia
ethanol
extract
nucifera
leav
exhibit
good
sarscov
pro
inhibitori
activ
lgml
follow
bioactivityguid
fraction
eight
diterpenoid
four
biflavonoid
isol
evalu
sarscov
pro
inhibit
use
fluoresc
reson
energi
transfer
analysi
compound
biflavon
amentoflavon
ic
lm
show
potent
pro
inhibitori
effect
three
addit
authent
flavon
apigenin
luteolin
quercetin
test
establish
basic
structureact
relationship
biflavon
apigenin
luteolin
quercetin
inhibit
pro
activ
ic
valu
lm
respect
valu
bind
energi
obtain
molecular
dock
studi
support
result
enzymat
assay
potent
activ
appear
associ
presenc
apigenin
moieti
posit
flavon
biflavon
effect
pro
inhibitori
activ
sever
acut
respiratori
syndrom
sar
contagi
often
fatal
respiratori
ill
first
report
guandong
provinc
china
novemb
rapid
unexpect
spread
asian
countri
north
america
europ
alarm
public
world
health
organ
sar
caus
novel
coronaviru
cov
sarscov
sarscov
positivestrand
rna
viru
whose
genom
sequenc
exhibit
moder
homolog
known
coronavirus
sarscov
encod
chymotrypsinlik
proteas
pro
also
call
main
proteas
pro
play
pivot
role
process
viral
polyprotein
control
replicas
complex
activ
enzym
indispens
viral
replic
infect
process
therebi
make
ideal
target
design
antivir
therapi
activ
site
contain
catalyt
dyad
cystein
residu
act
nucleophil
histidin
residu
act
gener
acidbas
date
sarscov
pro
inhibitor
report
synthet
peptidyl
compound
librari
natur
product
deriv
librari
inhibitori
synthet
compound
includ
diol
quinolinecarboxyl
acid
isatin
anilid
naturalderiv
inhibitor
includ
betulin
acid
indigo
aloeemodin
luteolin
quininemethid
triterpenoid
latter
product
latest
investig
pro
inhibitor
tripterygium
regelii
natur
molecul
found
ic
valu
rang
lm
enzym
assay
part
ongo
investig
potenti
sarscov
pro
inhibitor
medicin
plant
perform
initi
screen
ethanol
extract
leav
torreya
nucifera
use
fluoresc
reson
energi
transfer
fret
assay
nucifera
taxacea
tree
found
snowi
area
near
sea
jeju
island
korea
use
tradit
asian
medicin
remedi
stomachach
hemorrhoid
rheumatoid
arthriti
chosen
start
materi
virtu
observ
pro
inhibit
lgml
isol
phytochemicalseight
diterpenoid
four
biflavonoidswith
sarscov
pro
inhibitori
activ
ethanol
extract
leav
nucifera
isol
compound
examin
pro
inhibitori
activ
enzymat
inhibit
assay
isol
compound
biflavonoid
amentoflavon
identifi
potent
inhibitor
sarscov
pro
exhibit
ic
valu
lm
also
report
enzymeinhibit
mechan
ascertain
use
kinet
plot
molecular
dock
experi
crude
ethanol
extract
leav
nucifera
directli
analyz
hplc
chromatographi
shown
figur
princip
secondari
metabolit
peak
detect
chromatogram
photodiod
array
pda
nm
first
step
toward
relat
biolog
activ
principl
metabolit
assess
sarscov
pro
inhibitori
effect
nucifera
etoh
extract
along
nhexan
etoac
fraction
result
indic
nhexan
lgml
fig
etoac
fraction
lgml
fig
good
pro
inhibitori
activ
use
repeat
open
silica
gel
column
gel
sephadex
chromatographi
isol
bioactiv
compound
fraction
phytochem
investig
chemic
structur
unambigu
assign
basi
comprehens
spectral
analysi
mass
spectrometri
nmr
data
comparison
previous
publish
data
compound
isol
nhexan
fraction
identifi
known
diterpenoid
speci
hinokiol
ferruginol
methyl
dehydroabiet
isopimar
acid
kayadiol
etoac
fraction
yield
four
biflavonid
identifi
amentoflavon
bilobetin
ginkgetin
sciadopitysin
fig
investig
rel
inhibitori
potenc
compound
sarscov
pro
measur
sarscov
pro
activ
presenc
absenc
test
compound
use
fluorogen
method
unless
otherwis
state
compound
first
test
singl
maximum
concentr
lm
ic
determin
made
use
twofold
serial
dilut
state
lm
follow
previous
describ
protocol
test
phytochem
inhibit
sarscov
pro
dosedepend
manner
shown
figur
inhibitori
effect
isol
compound
pro
activ
vitro
summar
tabl
tabl
display
inhibitori
activ
eight
inhous
diterpenoid
librari
sarscov
pro
inhibitori
potenc
capac
affect
subtl
chang
structur
recent
studi
shyur
cowork
show
natur
occur
diterpenoid
inhibit
sarscov
pro
activ
concentr
less
lm
present
studi
found
compound
also
possess
similar
inhibitori
effect
toward
pro
half
test
compound
inhibit
sarscov
pro
concentr
lm
one
except
ferruginol
exhibit
significantli
greater
inhibitori
effect
pro
ic
lm
laboratori
assay
system
found
previou
studi
notabl
ferruginol
nearli
fourfold
potent
inhibitor
parent
abietan
diterpenoid
abiet
acid
ic
lm
separ
experi
assess
biflavonoid
deriv
inhibit
sarscov
pro
shown
tabl
found
ic
valu
biflavonoid
deriv
sarscov
pro
rang
lm
compound
amentoflavon
ic
lm
potent
sarscov
pro
inhibitor
best
knowledg
first
report
biolog
activ
biflavonoid
deriv
toward
sarscov
pro
next
perform
qualit
analysi
structuralact
relationship
compound
comparison
biflavon
amentoflavon
biflavon
deriv
reveal
methyl
hydroxyl
group
diminish
inhibitori
activ
wherea
nake
biflavon
amentoflavon
increas
inhibitori
activ
thu
compound
methoxi
group
less
potent
ic
lm
compound
lack
methoxi
group
also
found
locat
methoxi
group
within
compound
posit
correl
potenc
compound
sarscov
pro
termin
methoxi
group
requir
pro
inhibit
shown
compound
exhibit
moder
potenc
pro
howev
substitut
methoxi
group
appear
enhanc
potenc
compound
exampl
methoxi
group
investig
pro
inhibitori
profil
biflavon
detail
elucid
structureact
relationship
access
seri
authent
flavon
apigenin
luteolin
quercetin
fig
potent
inhibitor
exhibit
ic
valu
toward
sarscov
pro
lm
make
compound
potent
parent
compound
apigenin
threshold
valu
lm
experi
tabl
moreov
activ
higher
anoth
flavon
luteolin
ic
lm
case
flavon
flavon
substitut
hydroxyl
group
luteolin
potent
inhibitor
apigenin
thu
data
suggest
substitut
apigenin
motif
within
flavon
biflavonoid
may
play
pivot
role
sarscov
pro
inhibit
relationship
also
support
quercetin
ic
lm
hydroxyl
group
posit
flavon
fig
also
character
inhibitori
mechan
isol
biflavonoid
sarscov
pro
activ
repres
exampl
illustr
figur
show
inhibit
sarscov
pro
effect
compound
amentoflavon
enzym
inhibit
mechan
biflavonoid
model
use
doublereciproc
plot
lineweaverburk
dixon
plot
shown
figur
dixon
plot
versu
rfumin
result
famili
straight
line
xaxi
intercept
illustr
three
fluorogen
substrat
concentr
respect
indic
biflavonoid
exhibit
noncompetit
inhibit
characterist
toward
pro
v
max
decreas
without
chang
k
valu
presenc
increas
concentr
inhibitor
fig
k
valu
biflavonoid
easili
calcul
dixon
plot
common
intercept
xaxi
correspond
elucid
interact
sarscov
pro
biflavon
employ
silico
dock
simul
threedimension
structur
sarscov
pro
complex
substrateanalogu
inhibitor
code
obtain
protein
data
bank
pdb
http
wwwrcsborgpdb
use
model
analysi
comput
dock
analysi
reveal
biflavon
nice
fit
bind
pocket
pro
shown
figur
hydroxyl
group
form
two
hydrogen
bond
nitrogen
atom
imidazol
group
oh
belong
site
pro
addit
hydroxyl
group
b
ring
form
hydrogen
bond
belong
site
pro
studi
structureact
relationship
implic
interact
one
key
chemotyp
inhibitor
moreov
potenc
inhibitor
amentoflavon
apigenin
correl
well
bind
energi
amentoflavon
kcalmol
apigenin
kcalmol
differ
bind
energi
appar
manifest
smaller
ic
valu
amentofalvon
toward
pro
compar
apigenin
thu
dock
experi
support
infer
drawn
enzymat
assay
reveal
import
inhibitori
action
biflavon
sarscov
pro
conclus
result
confirm
amentoflavon
isol
nucifera
effect
inhibitor
sarscov
pro
effect
correspond
flavon
apigenin
luteolin
biflavonoid
deriv
contain
variou
number
methoxi
group
best
knowledg
first
report
describ
inhibitori
effect
amentoflavon
pro
ic
valu
inhibitor
although
higher
peptidederiv
pro
inhibitor
nonetheless
low
micromolar
rang
thu
believ
compound
may
good
candid
develop
natur
therapeut
drug
sarscov
infect
leav
torreya
nucifera
collect
jeju
island
republ
korea
octob
voucher
specimen
deposit
author
laboratori
kribb
korea
research
institut
bioscienc
biotechnolog
dri
leav
kg
nucifera
extract
three
time
l
ethanol
etoh
room
temperatur
day
ethanol
extract
g
suspend
h
result
aqueou
layer
success
partit
nhexan
ethyl
acet
etoac
h
yield
hexan
fraction
g
etoac
fraction
g
aqueou
fraction
g
hexanesolubl
fraction
subject
silica
gel
column
chromatographi
elut
use
stepwis
gradient
mixtur
nhexaneetoac
yield
eight
fraction
fraction
g
load
onto
silica
gel
column
elut
mixtur
nhexaneetoac
mobil
phase
yield
six
fraction
fraction
g
fraction
use
silica
gel
column
elut
mixtur
nhexaneetoac
yield
compound
mg
mg
fraction
g
chromatograph
column
rp
elut
acetonitrileh
yield
compound
mg
mg
mg
mg
mg
fraction
purifi
silica
gel
chromatographi
elut
nhexanech
cl
vv
yield
compound
mg
etoac
fraction
nucifera
subject
column
chromatographi
silica
gel
elut
chloroformtoaceton
gradient
yield
nine
fraction
fraction
g
chromatograph
sephadex
column
elut
methanol
yield
five
subfract
subfract
g
purifi
silica
gel
chromatographi
elut
nhexaneetoac
yield
compound
mg
sephadex
column
chromatographi
use
isol
compound
mg
fraction
g
use
ident
solvent
condit
subfract
subsequ
separ
chromatographi
preparativehplc
yield
compound
mg
mg
colorless
prism
c
chcl
mp
activ
c
fluoresc
control
enzym
buffer
substrat
min
incub
c
fluoresc
control
zero
time
fluoresc
test
sampl
enzym
sampl
solut
substrat
incub
fluoresc
test
sampl
zero
time
allow
quench
effect
sampl
sampl
solut
ad
reaction
mixtur
c
reduct
fluoresc
assess
kinet
paramet
obtain
use
variou
concentr
fret
peptid
fluoresc
assay
maxim
veloc
v
max
intens
min
michaelismenten
constant
k
lm
inhibit
constant
k
calcul
lineweaverburk
dixon
plot
molecular
dock
sarscov
pro
simul
analyz
use
autodock
softwar
sarscov
pro
crystal
structur
pdb
code
inhibitor
kcq
prepar
dock
postdock
refin
dock
experi
biflavon
water
molecul
inhibitor
kcq
locat
activ
site
remov
structur
inform
contain
amino
acid
residu
pro
enzym
use
autodocktool
softwar
use
addit
polar
hydrogen
atom
macromolecul
correct
calcul
partial
atom
charg
aspart
glutam
acid
deproton
lysin
arginin
proton
histidin
neutral
kollman
charg
assign
atom
three
dimension
affin
grid
size
activ
size
space
calcul
atom
type
use
autogrid
dock
paramet
lamarckian
genet
algorithm
pro
differ
biflavon
follow
popul
size
individu
random
start
posit
conform
translat
step
rang
maximum
energi
evalu
number
top
individu
surviv
next
gener
maximum
gener
mutat
rate
rate
crossov
local
search
rate
dock
run
maximum
number
iter
per
local
search
set
dock
job
produc
dock
conform
bind
energi
threedimension
structur
sarscov
pro
biflavon
calcul
dock
result
rank
accord
dock
energi
score
extract
mgml
fraction
mgml
pass
filter
millipor
msi
westboro
usa
chromatograph
separ
use
agil
hplc
system
agil
technolog
palo
alto
ca
usa
equip
quaternari
hplc
pump
degass
autosampl
uv
detector
vwd
mobil
phase
hplc
consist
water
solvent
acetonitril
solvent
b
solvent
gradient
follow
start
solvent
min
b
min
b
min
b
min
b
min
b
flow
rate
mlmin
inject
volum
eluent
detect
nm
hplc
analys
perform
